• Home
  • Products
  • News
  • Education
  • About us
  • …  
    • Home
    • Products
    • News
    • Education
    • About us
CE Marked Medical Device
  • Home
  • Products
  • News
  • Education
  • About us
  • …  
    • Home
    • Products
    • News
    • Education
    • About us
CE Marked Medical Device

VDI Technologies has finished development of new UHF-ECG amplifier

VDI Technologies announces the first version of their VDIAQ UHF-ECG amplifier, designed to provide a low-noise, battery-operated solution for an optimally shielded UHF-ECG signal acquisition unit. The VDIAQ UHF-ECG is intended for real-time, non-invasive visualization of ventricular activation and dyssynchrony for pacemakers placing physicians. This easy-to-be clinically implemented tool can be used in pre-operative patient selection, implant procedure, and post-operative care.

Section image

VDI Technologies CEO Mirek Navratil stated, "This new amplifier enables VDI to expand from a software provider to a company that provides a complete integrated application-ready solution. Full control over the design of all the key system components will help commercialize this novel UHF-ECG solution more quickly and easily."

The VDI UHF-ECG high sampling rate and low noise 14-channel design will enable a fast real-time signal analysis of frequency bandwidths up to 1000 Hz. The module is attached via optical cable to the state-of-an-art PC running VDI Vision software providing users with clear-to-read UHF-ECG maps with several EP-study features.

The first VDI amplifier-based system is being prepared for certification in Europe and the United States.

Market Opportunity

Pacing-induced cardio-myopathy resulting from suboptimal electrode placement has been recognized as a clinical challenge yet to be overcome. Electrophysiologists need a real-time, easy-to-operate, and easy-to-read peri-procedural tool that helps them assess if heartbeats are synchronous or dyssynchronous and increase the success rate of implant procedures. About 500k pacemakers are implanted annually between the U.S. and EU countries that would benefit from accurate ventricular dyssynchrony imaging.

 

Previous
VDI Technologies has received several prestigious awards
Next
VDI Technologies annouces series A financing
 Return to site
Cookie Use
We use cookies to improve browsing experience, security, and data collection. By accepting, you agree to the use of cookies for advertising and analytics. You can change your cookie settings at any time. Learn More
Accept all
Settings
Decline All
Cookie Settings
These cookies enable core functionality such as security, network management, and accessibility. These cookies can’t be switched off.
These cookies help us better understand how visitors interact with our website and help us discover errors.
These cookies allow the website to remember choices you've made to provide enhanced functionality and personalization.
Save